// App-Quantinova.ai

202 : Fifteen Year Outcomes in the Astellas Double Blind Randomized Controlled Trial (RCT) Comparing Early Corticosteroid Withdrawal (CSWD) and Long-Term Corticosteroid Therapy Continuation (CCS) in Kidney Transplantation

Researchers

Presenter

  • E. Woodle

Principal Investigators

  • S. Clark

  • D. Stewart

  • M. First

  • R. Alloway

  • J. Gill

Medical Centers

  • Colon and Rectal Surgery, University of Cincinnati College of Medicine, Cincinnati, OH

  • Providence Health Care, Vancouver, BC, Canada

  • UNOS, Richmond, VA

  • Transplant Genomics Inc. and Comprehensive Transplant Center, Northwestern University, Evanston, IL

  • Univ. of Cincinnati College of Medicine, Cincinnati, OH.

  • The University of British Columbia, Vancouver, BC, Canada

  • Yale University, New Haven, CT

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Optineurin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved